Interferon Beta-1A Injectable Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 30 mcg, 22 mcg or 44 mcg,125 mcg, 125 mcg, 150 mcg,175 mcg
Reference Brands: Avonex, Rebif, Plegridy(US &EU)
Category: Multiple sclerosis
Interferon Beta-1a reduces inflammation and modulates immune responses in multiple sclerosis by inhibiting pro-inflammatory cytokines and immune cell activity. It decreases relapse rates, slows disease progression, and reduces lesion development. Benefits include improved neurological function, symptom control, and enhanced quality of life for MS patients.
Product Description:
Interferon Beta-1a, marketed as Avonex, Rebif, and Plegridy, is approved in the US by the FDA and in the EU via EMA for multiple sclerosis treatment. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, FDA review involves detailed analysis of clinical trial results and manufacturing processes, while the EU ensures compliance with regional standards.
Interferon Beta-1A Injectable — third party manufacturing & bulk supply
Interferon Beta-1A Injectable is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Interferon Beta-1A Injectable listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Interferon Beta-1A Injectable →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Interferon beta-1a is used for the treatment of relapsing forms of multiple sclerosis (MS). It helps reduce the frequency of disease relapses and may slow the progression of physical disability. The medicine works by regulating immune system activity and reducing inflammation that can damage nerve cells in the central nervous system.
Interferon beta-1a is a recombinant protein produced using advanced biotechnology. It is manufactured through genetic engineering in mammalian cells to create a protein that is very similar to naturally occurring human interferon beta.
Common trade names of Interferon beta-1a include Avonex and Rebif.
Interferon beta-1a products are manufactured by companies such as Biogen and Merck KGaA, depending on the brand and region.
The generic name is Interferon beta-1a.
Well-known brand names include Avonex and Rebif.
Interferon beta-1a is manufactured in regulated biopharmaceutical production facilities in countries such as the United States and several European nations under strict quality and safety standards.
Related Products
Lamotriginevdispersible Tablets
Strength:
XR: 25 mg, 50 mg, 100 mg, 200 mg; IR: 25 mg, 100 mg, 200 mg, 300 mg
Form: Tablets(IR & ER)
Reference Brands: Lamictal, Lamictal XR(EU & US)
View Details
Dalfampridine
Strength:
10 mg
Form: Extended-Release tablets (XR)
Reference Brands: Ampyra(US)
View Details
Tizanidine Tablets/Capsules
Strength:
2 mg and 4 mg
Form: Oral Capsules/Tablets
Reference Brands: Zanaflex (US)
View Details
Baclofen Tablets:
Strength:
10 mg and 20 mg
Form: Tablet
Reference Brands: Lioresal, Gablofen(US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
